Stocks

Alphatec Holdings got a strong-buy rating. Why’s that?

Alphatec Holdings has undergone a transformation recently, thanks to its new management team. It is now operating as an innovative procedurally-driven spine company. Due to these changes and an affordable $4.45 share price, shareholders may significantly profit in the coming months.

Northland Capital’s analyst, Jason Wittes, noted that the restructuring included the sale of the stock’s international business. The company has also shifted away from lower-end distributors associated with lower profit and controversial Physician-Owned Distributors. All of this has enabled Alphatec Holdings to build strong R&D and sales teams, along with attracting Key Opinion Leaders. Wittes thinks that that, combined with a highly differentiated product portfolio, means Alphatec is now in a position for significant growth.

 

Alphatec Holdings offers unique new products

The company has given its product portfolio a major face-lift during its two-year transformational period. According to Wittes, they unveiled 12 products in 2019 alone, and they designed each around specific spinal fusion approaches.

Related Post

One of the firm’s products is SafeOP – the company’s new nerve monitoring platform, which has the unique ability to monitor nerve health in real-time, not just its position, for reproducibility and safety, especially when it comes to minimally invasive lateral procedures, as there is no direct visualization of the nerves in such procedures.

Furthermore, Alphatec Holdings plans to launch its Prone Transposes lateral procedure at the North American Spinal Society annual meeting in November. PTP reflects a new approach to lateral fusions and, as such, involves placing the patient in a prone position (stomach) instead of on their side.

Considering all these facts, Wittes rated the stock as a Buy rating, giving it a $9 price target. If the target is met, shares could skyrocket by 100% higher in the next twelve months.

Other analysts agree with Wittes as well, giving this stock a Strong Buy rating. The average price target is $8.38. This implies 85% growth over the year.

Recent Posts

AUD/JPY Climbs Back to 102.20, Halting Losses

Key Points: AUD/JPY broke below a rising wedge, signalling possible bearish momentum, with immediate resistance at 103.00 and support at…

3 days ago

EUR/JPY Hit 168.25, Boosted by 0.3% Q1 GDP Growth

Key Points EUR/JPY Rises to 168.25: Strengthened by robust Eurozone economy and steady ECB policy. Eurozone GDP Grew by 0.3%…

3 days ago

Chinese Electric Vehicle Market: Nio Stock Up 20%

Key Points: Nio's shares hit 44.20 HKD, up 20%, with electric vehicle deliveries up 134.6% year-on-year to 15,620. BYD leads…

4 days ago

Ethereum Price Dips Below $3,120 Amid Market Slump

Key Points: Ethereum fell sharply from $3,355 to a low of $2,813, reflecting high volatility and sensitivity to market dynamics.…

4 days ago

Stock Markets: Nikkei Down 0.1%, Hang Seng Up 2.4%

Key Points Nikkei 225 slightly fell by 0.1%, while the Hang Seng index surged by 2.4%. USD/JPY increased slightly, highlighting…

4 days ago

Gold Price Increases to ₹71,278 and $2,328

Key Points: Gold prices rose on MCX India to ₹71,278/10 gm and COMEX US to $2,328/oz. The US Dollar Index…

4 days ago

This website uses cookies.